159 related articles for article (PubMed ID: 38276943)
1. Advances in Screening for Barrett Esophagus and Esophageal Adenocarcinoma.
Vantanasiri K; Kamboj AK; Kisiel JB; Iyer PG
Mayo Clin Proc; 2024 Mar; 99(3):459-473. PubMed ID: 38276943
[TBL] [Abstract][Full Text] [Related]
2. Innovations in Screening Tools for Barrett's Esophagus and Esophageal Adenocarcinoma.
Bell MG; Iyer PG
Curr Gastroenterol Rep; 2021 Oct; 23(12):22. PubMed ID: 34654955
[TBL] [Abstract][Full Text] [Related]
3. Novel Screening Tests for Barrett's Esophagus.
Codipilly DC; Iyer PG
Curr Gastroenterol Rep; 2019 Jul; 21(9):42. PubMed ID: 31346777
[TBL] [Abstract][Full Text] [Related]
4. Barrett esophagus: when to endoscope.
Butt J; Kandel G
Clin Endosc; 2014 Jan; 47(1):40-6. PubMed ID: 24570882
[TBL] [Abstract][Full Text] [Related]
5. Advanced endoscopic imaging for detection of Barrett's esophagus.
Zilberstein N; Godbee M; Mehta NA; Waxman I
Clin Endosc; 2024 Jan; 57(1):1-10. PubMed ID: 38178326
[TBL] [Abstract][Full Text] [Related]
6. Barrett Esophagus.
Iyer PG; Kaul V
Mayo Clin Proc; 2019 Sep; 94(9):1888-1901. PubMed ID: 31486383
[TBL] [Abstract][Full Text] [Related]
7. Novel Screening Alternatives for Barrett Esophagus.
Krishna Chandar A; Sharma A; Chak A
Gastroenterol Hepatol (N Y); 2020 May; 16(5):238-245. PubMed ID: 34035726
[TBL] [Abstract][Full Text] [Related]
8. 2017 David Sun Lecture: Screening and Surveillance of Barrett's Esophagus: Where Are We Now and What Does the Future Hold?
Falk GW
Am J Gastroenterol; 2019 Jan; 114(1):64-70. PubMed ID: 30361622
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale markers of esophageal field carcinogenesis: potential implications for esophageal cancer screening.
Konda VJ; Cherkezyan L; Subramanian H; Wroblewski K; Damania D; Becker V; Gonzalez MH; Koons A; Goldberg M; Ferguson MK; Waxman I; Roy HK; Backman V
Endoscopy; 2013 Dec; 45(12):983-8. PubMed ID: 24019132
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis.
Codipilly DC; Chandar AK; Singh S; Wani S; Shaheen NJ; Inadomi JM; Chak A; Iyer PG
Gastroenterology; 2018 Jun; 154(8):2068-2086.e5. PubMed ID: 29458154
[TBL] [Abstract][Full Text] [Related]
11. Point-Counterpoint: Screening and Surveillance for Barrett's Esophagus, Is It Worthwhile?
Otaki F; Iyer PG
Dig Dis Sci; 2018 Aug; 63(8):2081-2093. PubMed ID: 29713986
[TBL] [Abstract][Full Text] [Related]
12. Screening and surveillance of Barrett's esophagus.
Michalak J; Bansal A; Sharma P
Curr Gastroenterol Rep; 2009 Jun; 11(3):195-201. PubMed ID: 19463219
[TBL] [Abstract][Full Text] [Related]
13. Cost Effectiveness of Screening Patients With Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device.
Heberle CR; Omidvari AH; Ali A; Kroep S; Kong CY; Inadomi JM; Rubenstein JH; Tramontano AC; Dowling EC; Hazelton WD; Luebeck EG; Lansdorp-Vogelaar I; Hur C
Clin Gastroenterol Hepatol; 2017 Sep; 15(9):1397-1404.e7. PubMed ID: 28238953
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic Screening for Barrett's Esophagus and Esophageal Adenocarcinoma: Rationale, Candidates, and Challenges.
Kamboj AK; Katzka DA; Iyer PG
Gastrointest Endosc Clin N Am; 2021 Jan; 31(1):27-41. PubMed ID: 33213798
[TBL] [Abstract][Full Text] [Related]
15. Goblet Cell Ratio in Combination with Differentiation and Stem Cell Markers in Barrett Esophagus Allow Distinction of Patients with and without Esophageal Adenocarcinoma.
Schellnegger R; Quante A; Rospleszcz S; Schernhammer M; Höhl B; Tobiasch M; Pastula A; Brandtner A; Abrams JA; Strauch K; Schmid RM; Vieth M; Wang TC; Quante M
Cancer Prev Res (Phila); 2017 Jan; 10(1):55-66. PubMed ID: 27807078
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic biomarkers in esophageal cancer.
Kaz AM; Grady WM
Cancer Lett; 2014 Jan; 342(2):193-9. PubMed ID: 22406828
[TBL] [Abstract][Full Text] [Related]
17. Molecular biomarkers added to image-enhanced endoscopic imaging: will they further improve diagnostic accuracy?
Krishnamoorthi R; Iyer PG
Best Pract Res Clin Gastroenterol; 2015 Aug; 29(4):561-73. PubMed ID: 26381302
[TBL] [Abstract][Full Text] [Related]
18. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
Sostres C; Lacarta P; Lanas A
Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
[TBL] [Abstract][Full Text] [Related]
19. Barrett Esophagus and Intramucosal Esophageal Adenocarcinoma.
Rajendra S; Sharma P
Hematol Oncol Clin North Am; 2017 Jun; 31(3):409-426. PubMed ID: 28501084
[TBL] [Abstract][Full Text] [Related]
20. Advances in the management of Barrett's esophagus and early esophageal adenocarcinoma.
Singh A; Chak A
Gastroenterol Rep (Oxf); 2015 Nov; 3(4):303-15. PubMed ID: 26486568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
